Clinical Trial

Chloroprocaine 1% Versus Ropivacaine 0,75% During Cesarean Section

Study acronym: annie-mariana
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated July 22, 2025 (before its estimated January 10, 2026 completion). Its status may not reflect the trial's current state.
Summary
This will be a prospective randomized study, aiming at comparing an intrathecal fixed dose of chloroprocaine 1% versus an intrathecal fixed dose of ropivacaine 0.75% in elective cesarean sections
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-04-17.
Trial Details
NCT Number NCT06376058
Lead Sponsor Aretaieion University Hospital
Conditions Cesarean Section, Local Anesthetic
Enrollment 60 participants
Start Date 2024-01-10
Primary Completion 2026-01-10 (estimated)
Study Completion 2026-01-10 (estimated)
Updated on ClinicalTrials.gov 2025-07-22